Synthetic Vaccine Particles (SVP) technology is a highly flexible nanoparticle platform, capable of incorporating a wide range of antigens and immunomodulators, allowing to tailor SVP products for inducing specific immune responses. SVP are designed to remain intact after injection into the body and accumulate selectively in lymphoid organs, which include lymph nodes and the spleen, where the immune response is coordinated. Depending on the type of immunomodulator encapsulated in the SVP, our technology is capable of either inducing a
- tolerogenic response to a biologic drug to
mitigate the formation of ADAs
- potent antigen-specific stimulatory response,
such as an antibody response to a microbial antigen or a cytolytic T cell
response to a tumor antigen.